References
- Asaka M, Kato M, Kudo M, et al (1995). Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population. Eur J Gastroenterol Hepatol, 1, 7-10.
- Bond GL, Hu W, Levine AJ, et al (2005). Mdm2 is a central node in the p53 pathway: 12 years and counting. Curr Cancer Drug Targets, 5, 3-8. https://doi.org/10.2174/1568009053332627
- Cai L, Yu SZ, Zhang ZF, et al (2000). Helicobacter pylori infection and risk of gastric cancer in Changle County, Fujian Province, China. World J Gastroenterol, 6, 374-6. https://doi.org/10.3748/wjg.v6.i3.374
- Dixon MF, Genta RM, Harley JH, et al (1996). Classification and grading of gastritis: The updated Sydney system. Am J Surgical Pathol, 20, 1161-81.
- Gurova KV, Hill JE, Guo C, et al (2005). Small molecules that reactivate p53 in renal cell Haupt, carcinoma reveals a nfkappab- dependent mechanism of p53 suppression in tumors. Proc Natl Acad Sci U. S. A, 102, 17448-53. https://doi.org/10.1073/pnas.0508888102
- Haupt Y, Maya R, Kazaz A, et al (1997). Mdm2 promotes the rapid degradation of p53. Nature, 387, 296-9. https://doi.org/10.1038/387296a0
- Honda R, Tanaka H, Yasuda H, (1997). Oncoprotein MDM2 is an ubiquitin ligase E3 for tumor suppressor p53. FEBS Letters, 420, 25-7. https://doi.org/10.1016/S0014-5793(97)01480-4
- Holcombe C (1992). Helicobacter pylori: the African enigma. Gut, 33, 429-31. https://doi.org/10.1136/gut.33.4.429
- Kate V and Ananthakrishnan N (2000). Helicobacter pylori and gastric carcinoma: evidence for the link. Natl Med J India, 13, 329.
- Kate V, Ananthakrishnan N, Badrinath S, et al (1998). Prevalence of Helicobacter pylori infection in disorders of the upper gastrointestinal tract in south India. Natl Med J India, 11, 5-8.
- Khanna AK, Seth P, Nath G, et al (2002). Correlation of Helicobacter pylori and gastric carcinoma. J Postgrad Med, 48, 27-8.
- Komarova EA, Krivokrysenko V, Wang K, et al (2005). P53 is a suppressor of inflammatory response in mice. Faseb J Official Publicat Federation Of American Societies For Experimental Biol, 19, 1030-2. https://doi.org/10.1096/fj.04-3213fje
- Kubbutat MH and Jones SN (1997). Regulation of p53 stability by Mdm2. Nature, 387, 299-303. https://doi.org/10.1038/387299a0
- Lowe J, Shatz M, Resnick MA, et al (2013). Modulation of immune responses by the tumor suppressor p53. Bio Discovery, 8, 2.
- Momand J and Zambetti GP (1992). The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69, 1237-45. https://doi.org/10.1016/0092-8674(92)90644-R
- Moradi MT, Salehi Z, Aminian K, et al (2014). Effects of p53 codon 72 and MDM2 SNP309 polymorphisms on gastric cancer risk among the Iranian population. Asian Pac J Cancer Prevc, 15, 7413-7. https://doi.org/10.7314/APJCP.2014.15.17.7413
- O'Prey J, Crighton D, Martin AG, et al (2010). P53-mediated induction of noxa and p53aip1 requires nfkappab. Cell Cycle, 9, 947-52. https://doi.org/10.4161/cc.9.5.10872
- Picksley SM, Lane DP (1993). The p53-mdm2 autoregulatory feedback loop: a paradigm for the regulation of growth control by p53?. Bioessays, 15, 689-90. https://doi.org/10.1002/bies.950151008
- Sivaprakash R, Rao UA, Thyagarajan SP, et al (1996). Investigation for the prevalence of hselicobacter pylori infection in patients with gastric carcinoma in Madras, India. Jpn J Med Sci Biol, 49, 49-56. https://doi.org/10.7883/yoken1952.49.49
- Taweesak T, Soraya K, Natthawut K, et al (2015). Correlation between gastric mucosal morphologic patterns and histopathological severity of helicobacter pylori associated gastritis using conventional narrow band imaging gastroscopy. Bio Med Res Int, 7, 42-8.
- Tergaonkar V, Pando M, Vafa O, et al (2002). P53 stabilization is decreased upon nf kappa b activation : A role for nfkappab in acquisition of resistance to chemotherapy. Cancer Cell, 1, 493-503. https://doi.org/10.1016/S1535-6108(02)00068-5
- Wang X, Yang J, Ho B, et al (2009). Interaction of helicobacter pylori with genetic variants in the MDM2 promoter is associated with gastric cancer susceptibility in Chinese patients. Helicobacter, 14, 114-9.
Cited by
- Toll-Like Receptors are Associated with Helicobacter pylori Infection and Gastric Mucosa Pathology vol.In Press, pp.In Press, 2017, https://doi.org/10.5812/jjm.58351
- Genetic polymorphisms in TLR1, TLR2, TLR4, and TLR10 of Helicobacter pylori-associated gastritis vol.27, pp.2, 2018, https://doi.org/10.1097/CEJ.0000000000000347